Immanuel Thangaraj - May 25, 2021 Form 4 Insider Report for ACURA PHARMACEUTICALS, INC (ACUR)

Role
Director
Signature
/s/ Immanuel Thangaraj
Stock symbol
ACUR
Transactions as of
May 25, 2021
Transactions value $
$0
Form type
4
Date filed
5/28/2021, 04:11 PM
Next filing
Jan 12, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ACUR Restricted Stock Units (2021 Plan) Award +66.7K 66.7K May 25, 2021 Common Stock 66.7K Direct F1, F2, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Par value of $.01 per share must be paid by Reporting Person upon exchange of Restricted Stock Units for stock.
F2 1 - for - 1
F3 N/A
F4 50% of Restricted Stock Units vest on the last day of June 2021, while 25% of Restricted Stock Units vest on the last day of September 2021 and December 2021, subject to immediate vesting in the event of a change of control and certain other events. Reporting Person may elect to exchange up to 40% of Restricted Stock Units for cash and the remaining Restricted Stock Units will be exchanged on a one for one basis for common stock, in each case upon payment of, or deduction of par value. Distributions in respect of vested Restricted Stock Units will be made on the first business day of January 2022, or earlier upon a change of control.